A Phase 2 Study of AZD2171 (Cediranib) With Modified FOLFOX6 in Patients With Advanced Biliary Cancers.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Cediranib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer; Liver cancer
- Focus Therapeutic Use
- 10 Feb 2017 Status changed from completed to discontinued.
- 19 Sep 2016 Status changed from active, no longer recruiting to completed.
- 01 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.